APA

Soldatova Y. V., Kotelnikova R. A., Zhilenkov A. V., Faingold I. I., Troshin P. A., Kozlova M. A., Areshidze D. A. & Aldoshin S. M. (20200319). Potassium Salt of Fullerenylpenta-N-Dihydroxytyrosine Effects on Type 2 Diabetes Mellitus Therapeutic Targets. : Doklady. Biochemistry and biophysics.

Chicago

Soldatova Yu V, Kotelnikova R A, Zhilenkov A V, Faingold I I, Troshin P A, Kozlova M A, Areshidze D A and Aldoshin S M. 20200319. Potassium Salt of Fullerenylpenta-N-Dihydroxytyrosine Effects on Type 2 Diabetes Mellitus Therapeutic Targets. : Doklady. Biochemistry and biophysics.

Harvard

Soldatova Y. V., Kotelnikova R. A., Zhilenkov A. V., Faingold I. I., Troshin P. A., Kozlova M. A., Areshidze D. A. and Aldoshin S. M. (20200319). Potassium Salt of Fullerenylpenta-N-Dihydroxytyrosine Effects on Type 2 Diabetes Mellitus Therapeutic Targets. : Doklady. Biochemistry and biophysics.

MLA

Soldatova Yu V, Kotelnikova R A, Zhilenkov A V, Faingold I I, Troshin P A, Kozlova M A, Areshidze D A and Aldoshin S M. Potassium Salt of Fullerenylpenta-N-Dihydroxytyrosine Effects on Type 2 Diabetes Mellitus Therapeutic Targets. : Doklady. Biochemistry and biophysics. 20200319.